SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-033744
Filing Date
2020-12-14
Accepted
2020-12-14 16:42:22
Documents
2
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1561
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 3871
  Complete submission text file 0000899243-20-033744.txt   6822
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Issuer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address
Karydas Daphne (Reporting) CIK: 0001816952 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38707 | Film No.: 201386664